
Sign up to save your podcasts
Or
Clinical evidence indicates that cigarette smoking negatively impacts the incidence and severity of fatty liver disease, fibrosis progression, hepatocellular carcinoma development, and the outcomes of patients with advanced liver disease. The underlying mechanisms are complex and involve different pathophysiological pathways including oxidative stress and oncogenic signals.
To coincide with World No Tobacco Day, 31 May, this EASL Studio discusses some of the pathophysiological mechanisms that drive the progression of liver disease and cancer risk in those who smoke.
Faculty
All EASL Studio Podcasts are available on EASL Campus.
Clinical evidence indicates that cigarette smoking negatively impacts the incidence and severity of fatty liver disease, fibrosis progression, hepatocellular carcinoma development, and the outcomes of patients with advanced liver disease. The underlying mechanisms are complex and involve different pathophysiological pathways including oxidative stress and oncogenic signals.
To coincide with World No Tobacco Day, 31 May, this EASL Studio discusses some of the pathophysiological mechanisms that drive the progression of liver disease and cancer risk in those who smoke.
Faculty
All EASL Studio Podcasts are available on EASL Campus.
7 Listeners
314 Listeners
1 Listeners
492 Listeners
43,356 Listeners
3,325 Listeners
90 Listeners
1,116 Listeners
976 Listeners
365 Listeners
37 Listeners
16 Listeners
0 Listeners
2,136 Listeners
4 Listeners